Markets
local & international
Asia Pacific
Currencies
Commodities
UK
North America
News
latest news
Latest News
Most Viewed
Business
Currencies
Economy
Markets
Property
Technology
Portfolio
analysis & tools
Portfolios
Alerts
Filters
Reports
Watchlists
Help
Products
products & services
Charting
Data Agent
Data Subscriptions
Historical Data
Investment Game
Pricing
Real Edge
Download
Login
Register
Friday, 26 April 2024
Biogen Idec Inc
NASDAQ
BIIB
Summary
|
Chart
|
News
|
History
|
More info..
Recent News
More news...
Biogen's Bargain Price May Spur a 14% Stock Gain
07:33 | 14/3/18
Investopedia (blog)
(Note: The author of this fundamental analysis is a financial writer and portfolio manager. He and his clients own shares of CELG.
more»
Buy or Sell? Average Brokerage Ratings on Biogen Inc. (BIIB), La Quinta ...
05:30 | 14/3/18
StockNewsJournal
Investors who are keeping close eye on the stock of Biogen Inc. (NASDAQ:BIIB) established that the company was able to keep return on investment at 19.33 in the trailing twelve month while Reuters data showed that industry's average stands at 14.08 and ...
more»
Biogen to Buy Mid-Stage Neuropsychiatry Asset From Pfizer
03:03 | 14/3/18
Nasdaq
Biogen Inc. BIIB has agreed to acquire a phase IIb ready candidate, PF-04958242, which is being developed for cognitive impairment associated with schizophrenia (CIAS) from pharma giant Pfizer, Inc. PFE .
more»
Biogen to buy schizophrenia drug from Pfizer for up to US$590mln
01:22 | 13/3/18
Proactive Investors UK
Biogen Inc (NASDAQ:BIIB) has agreed to buy a Phase IIb trial-ready schizophrenia treatment from fellow pharma giant Pfizer Inc (NYSE:PFE), in a deal worth up to US$590mln.
more»
Biogen Inc (NASDAQ:BIIB): Are Forecast Margins sustainable?
05:30 | 10/3/18
Simply Wall St
Biogen's encouraging earnings sentiment drives analysts to forecast substantial growth of 84.82% over the next year, but let's stop and think through this projection.
more»
Biogen (BIIB) a Sell This Week
04:11 | 10/3/18
Investorplace.com
At $286.95, Biogen (BIIB) a Sell based on the most recent stock market rankings, and comparative pricing of its shares. Biogen Inc's (NASDAQ:BIIB) current Sell recommendation is the result of a ranking in the company's industry group that is in the ...
more»
May This Data Fuel Up Investor's Confidence – Biogen Inc (NASDAQ: BIIB)
03:15 | 10/3/18
Alpha Beta Stock
The Russell 2000, the top index for companies that have market values much lower than the giants of the Dow and S&P 500, is up 2% so far in March.
more»
Technical Indicators in Focus – Biogen Inc (NASDAQ: BIIB)
04:26 | 9/3/18
Stocks Pen
The S&P 500 index and the Dow Jones Industrial Average closed lower Wednesday as the resignation of top White House economic adviser Gary Cohn stoked fears of a trade war but the tech-laden Nasdaq bucked the trend to extend its winning streak to a ...
more»
Biogen Inc (BIIB) Holdings Trimmed by Thrivent Financial For Lutherans
11:07 | 8/3/18
StockNewsTimes
Thrivent Financial For Lutherans owned approximately 0.15% of Biogen worth $98,588,000 at the end of the most recent quarter.
more»
Biogen, AbbVie's Zinbryta, yanked from market, connected to three US cases of ...
05:56 | 8/3/18
MarketWatch
The Food and Drug Administration is reviewing whether a type of brain inflammation called encephalitis connected to Biogen Inc. BIIB, -0.50% and AbbVie Inc.'s ABBV, +0.14% multiple sclerosis drug Zinbryta was a result of known side effects of the ...
more»
1
2
3
4
5
6
7
8
9
10
11
next»
Global Indices
Code
Last
Change
COMP
10,321
328
3.08%
DJI
29,635
404
1.34%
SP500
3,583
87
2.37%
DAX
12,438
82
0.67%
FTSE
7,488
5
0.07%
NI225
22,420
408
1.86%
TWI
67.27
0.00
0.00%
More news...
No news available...
Currencies
Code
Last
Change
EURUSD
0.9721
0.0055
0.56%
NZDUSD
0.5548
0.0093
1.65%
AUDUSD
0.6194
0.0107
1.70%
NZDAUD
0.8964
0.0010
0.11%